BMRN - Biomarin Pharmaceutical Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

15.1B

Cash

1.171B

Avg Qtr Burn

N/A

Short % of Float

3.76%

Insider Ownership

0.49%

Institutional Own.

97.77%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
VOXZOGO (vosoritide) Details Achondroplasia, Genetic Short Stature Conditions	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ROCTAVIAN (Valoctocogene roxaparvovec) Details Hemophilia	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VOXZOGO (vosoritide) Details Achondroplasia, Genetic Short Stature Conditions	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VOXZOGO Details Genetic Short Stature Conditions, Achondroplasia, Hypochondroplasia	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.